Featured Articles

• How to Spot Early Signs of Eye Disease and Prevent Vision Loss 13-04-2026

  Eye health is easy to take for granted until something starts to change. The problem is that many eye diseases do not begin with dramatic symptoms. They often develop quietly, and by the time vision changes become obvious, some damage may already hav

  READ MORE
• Young Australians turning to AI for mental health help 13-04-2026

  More than a quarter of people aged under 24 are using artificial intelligence to bolster their mental health as the cost of professional help bites. A survey of more than 2300 young people in NSW found mental health and cost of living pressures ar

  READ MORE
• 'Heartbreaking': mum's plea as allergy crisis worsens 12-04-2026

  When the cake is cut at a friend's birthday party, nine-year-old Edward knows he won't get a slice. It was a similar story at daycare, where the NSW student learned to expect a bowl of muesli when his classmates were given cupcakes.[subscr

  READ MORE
• 'World of hurt': AFL great's cancer warning for men 12-04-2026

  Sam Docherty was at the height of his AFL career when a small lump out of place threatened to derail it all. The then Carlton co-captain made the accidental discovery at a Gold Coast hotel in late 2020.[subscribe] "I was feeling around, as

  READ MORE
• Trial to reshape 'gruelling, traumatic' IVF process 12-04-2026

  Cancer patients and women with hormonal disorders are among those who may benefit from a breakthrough fertility treatment that eliminates a gruelling two weeks worth of injections. Melbourne GP Jilly Gallagher, who has undergone three rounds of eg

  READ MORE
• FDA Accepts NDA for TLX101-Px (Pixclara) 10-04-2026

  MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Company&#

  READ MORE
• ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate D 10-04-2026

  SHANGHAI, April 10, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a novel long-acting antiviral dru

  READ MORE
• Vaccine fatigued Aussies vulnerable to big flu season 09-04-2026

  Slumping vaccination rates have left Australia unprepared for another significant flu season that's being worsened by a new fast-spreading strain. Doctors issued the warning after 2025's record season, during which more than half a million

  READ MORE
• Mixed message: financial hurdle to quitting smoking 09-04-2026

  It can cost more to quit smoking than to continue puffing away on black-market cigarettes. Australia's approach of heavily taxing cigarettes while failing to widely subsidise quit aids is working against those most in need of support, the auth

  READ MORE
• Facts over fear: data needed on brain fog in menopause 09-04-2026

  Women experiencing or preparing for menopause need facts rather than fear-mongering, experts say, calling for further research into the prevalence of cognitive challenges such as brain fog. Women typically enter menopause between 45 and 60 and per

  READ MORE